An explainer on what side effects people may notice with the oral version of Wegovy. Tap through for the specifics the piece lists.
Recap by typeshit. Full story at BusinessWorld Online.
Mounjaro became India's top-selling drug in 2025, and a Scroll investigation reports that pharmacies are handing it out without the prescription it requires.
The Sunrise health expert says unregulated peptide use can put people in hospital, and in the worst cases leave them needing a new liver.
Some people on weight loss drugs are testing lower doses, hoping for fewer side effects. ThePrint reports on the trend, which these users describe themselves.
Bell raises the question of muscle loss for people losing weight on a GLP-1 and notes it isn't medical advice, pointing viewers to their doctor.
The analysis points to CagriSema filings, a DKK 15b buyback and Wegovy pill capacity, while flagging margin pressure and flat 2026 guidance as risks.
Health Minister Frank Vandenbroucke has ended reimbursement of Mounjaro as an obesity drug in Belgium. The Brussels Times has the details.
Loading…